WebApr 11, 2024 · Inovio Pharmaceuticals Inc. closed $2.72 below its 52-week high ($3.45), which the company reached on April 13th. ... Anheuser-Busch CEO on the Bud Light backlash: ‘We never intended to be part ... WebApr 12, 2024 · INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today announced that an abstract has been accepted for presentation for INO-4201 as an Ebola booster for rVSV-ZEBOV (Ervebo) at …
Inovio Pharmaceuticals, Inc. - INOVIO Announces Acceptance of …
WebJan 15, 2024 · Dr. J. Joseph Kim, Inovio's President & CEO said, "We are fortunate to have Jay Shepard join Inovio's Board of Directors. Jay's expertise in health care, corporate … WebMay 10, 2024 · The company's net loss of $79.1M in the quarter compares to a loss of $54.4M in Q1 2024. Inovio ( INO) also used its earnings release to state that Jacquelimne Shea has taken over as CEO,... pinkfong christmas fun
Inovio Pharmaceuticals, Inc. - INVESTORS & MEDIA
WebJACQUELINE SHEA, Ph.D. PRESIDENT & CHIEF EXECUTIVE OFFICER “We are entering a new era in DNA medicines and INOVIO is forging the path by bringing a 21st century approach … WebFor its 2024 fiscal year, INOVIO PHARMACEUTICALS, INC., listed the following CEO pay ratio data on its annual proxy statement to the SEC. Board of Directors in INOVIO PHARMACEUTICALS, INC. For its 2024 fiscal year, INOVIO PHARMACEUTICALS, INC., listed the following board members on its annual proxy statement to the SEC. WebSep 29, 2010 · BLUE BELL, Pa., Sep 29, 2010 (BUSINESS WIRE) -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Dr. Joseph Kim, President & CEO, has been named Life Sciences CEO of the Year by the Philadelphia Business Journal … pinkfong christmas medley